Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Top Performance

Predictions

buy
iBio Inc.

Start price
Target price
Perf. (%)
€25.75
14.12.20
€50.00
14.12.21
-45.17%
15.12.21

Could be worthwhile Investment >10% per year
Future proof or reliable business model
yester 
14.12.20 50%
buy
BELLUS Health Inc.

Start price
Target price
Perf. (%)
€4.95
10.10.21
€8.00
31.12.23
58.11%
13.12.21

Could be very worthwhile Investment >20% year
IfYouCanDreamItYouCanDoIt 
10.10.21 60%
buy
Cidara Therapeutics Inc

Start price
Target price
Perf. (%)
€1.31
27.11.21
-
27.11.22
11.62%
12.12.21

Risky Investment
daimler1 
27.11.21 50%
buy
Cti Biopharma Corp

Start price
Target price
Perf. (%)
€1.43
01.12.21
-
01.12.22
20.66%
12.12.21

Risky Investment
daimler1 
01.12.21 50%
buy
BELLUS Health Inc.

Start price
Target price
Perf. (%)
€4.62
02.12.21
-
02.12.22
45.82%
12.12.21

Risky Investment
daimler1 
02.12.21 50%
sell
Dare Bioscience Inc.

Start price
Target price
Perf. (%)
€2.80
08.12.21
-
08.12.22
-41.43%
10.12.21

Risky Investment
Wolf_of_WS 
08.12.21 50%
buy
iBio Inc.

Start price
Target price
Perf. (%)
€17.28
02.11.21
€22.50
02.11.22
-11.72%
05.12.21

Capable Management
Good culture
Valuable balance sheet
Dependend from some customers or products
geldnutzer 
02.11.21 60%
buy
Nuvo Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€0.94
15.09.21
€1.20
15.09.22
11.23%
05.12.21

Future proof or reliable business model
Could be worthwhile Investment >10% per year
Higher risks for its business
Below average Marketposition
tbackenh 
15.09.21 60%
buy
Seelos Therapeutics Inc.

Start price
Target price
Perf. (%)
€2.02
14.07.21
-
14.07.22
-24.07%
05.12.21

Mori8 
14.07.21 50%
buy
Valbiotis

Start price
Target price
Perf. (%)
€7.05
26.09.21
€7.50
26.09.22
-11.49%
26.11.21

Could be worthwhile Investment >10% per year
melinda 
26.09.21 50%
buy
Kazia Therapeutics ADR

Start price
Target price
Perf. (%)
€10.50
19.11.20
-
19.11.21
-28.57%
19.11.21

Risky Investment
Langfinger 
19.11.20 50%
buy
Riot Blockchain Inc.

Start price
Target price
Perf. (%)
€24.07
18.10.21
€36.00
18.10.22
31.49%
17.11.21

Revenue growth >5% per year expected
Could be worthwhile Investment >10% per year
Future proof or reliable business model
Risky balance sheet
tbackenh 
18.10.21 50%
buy
Nanorepro AG

Start price
Target price
Perf. (%)
€3.38
26.11.20
-
16.11.21
198.22%
17.11.21

Could be worthwhile Investment >10% per year
Standard Investments for future growth
Revenue growth >5% per year expected
Lower EBIT Margin than peer group
Amped 
26.11.20 0%
sell
Aptevo Therapeutics Inc.

Start price
Target price
Perf. (%)
€35.20
16.11.20
-
16.11.21
-77.34%
17.11.21

Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
WatchMen 
16.11.20 50%
sell
Alterity Therapeutics Ltd. ADR

Start price
Target price
Perf. (%)
€25.50
16.11.20
-
16.11.21
-60.78%
17.11.21

Probably not worthwhile Investment
marge 
16.11.20 50%
buy
Aptevo Therapeutics Inc.

Start price
Target price
Perf. (%)
€42.00
19.11.20
€50.00
19.11.21
-67.07%
07.11.21

Could be very worthwhile Investment >20% year
marge 
19.11.20 50%
buy
Rewalk Robotics Ltd.

Start price
Target price
Perf. (%)
€1.19
05.10.21
-
05.10.22
41.25%
05.11.21

Could be worthwhile Investment >10% per year
Sievi 
05.10.21 0%
sell
Bio-Gate AG

Start price
Target price
Perf. (%)
€5.90
04.11.20
-
04.11.21
-32.20%
05.11.21

Growths faster than the competition
Few uniques
Dependend from some customers or products
Probably not worthwhile Investment
shadow 
04.11.20 50%
buy
BioLine RX Ltd ADR

Start price
Target price
Perf. (%)
€2.46
03.11.20
€3.50
04.11.21
-4.88%
05.11.21

Could be worthwhile Investment >10% per year
melinda 
03.11.20 50%
sell
Novacyt S.A.

Start price
Target price
Perf. (%)
€10.10
19.10.20
-
04.11.21
-72.31%
05.11.21

Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
shadow 
19.10.20 50%
buy
Vaxart Inc.

Start price
Target price
Perf. (%)
€6.10
27.09.20
-
04.11.21
-1.25%
05.11.21

Higher risks for its business
Wann 
27.09.20 50%
sell
Cardiff Oncology Inc.

Start price
Target price
Perf. (%)
€9.90
22.09.20
-
04.11.21
-49.70%
05.11.21

Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
shadow 
22.09.20 50%
sell
Edesa Biotech Inc

Start price
Target price
Perf. (%)
€6.15
21.09.20
€4.00
04.11.21
17.07%
05.11.21

Probably not worthwhile Investment
High valuation
yester 
21.09.20 50%
buy
Vaxart Inc.

Start price
Target price
Perf. (%)
€4.22
09.09.20
€8.00
04.11.21
42.75%
05.11.21

Could be worthwhile Investment >10% per year
melinda 
09.09.20 50%
buy
Riot Blockchain Inc.

Start price
Target price
Perf. (%)
€2.66
13.08.20
€25.00
04.11.21
975.97%
05.11.21

Could be worthwhile Investment >10% per year
Future proof or reliable business model
yester 
13.08.20 0%